Back to square one: the role of septal reduction therapy in the era of Mavacamten

Ryan Wallace , Ryan Kabir , Sumbal Janjua , Patrick Bering , Toby Rogers
{"title":"Back to square one: the role of septal reduction therapy in the era of Mavacamten","authors":"Ryan Wallace ,&nbsp;Ryan Kabir ,&nbsp;Sumbal Janjua ,&nbsp;Patrick Bering ,&nbsp;Toby Rogers","doi":"10.1016/j.crmic.2025.100066","DOIUrl":null,"url":null,"abstract":"<div><div>An 86-year-old-female with hypertrophic cardiomyopathy with persistent obstructive symptoms despite beta blockers and disopyramide was trialed on mavacamten. Although she had improvement in obstructive symptoms, mavacamten was stopped due to reduction in left ventricular ejection fraction even on the lowest dose. Instead, alcohol septal ablation was pursued. This case highlights key considerations surrounding septal reduction therapy in the era of mavacamten.</div></div>","PeriodicalId":100217,"journal":{"name":"Cardiovascular Revascularization Medicine: Interesting Cases","volume":"7 ","pages":"Article 100066"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Revascularization Medicine: Interesting Cases","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2950275625000127","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

An 86-year-old-female with hypertrophic cardiomyopathy with persistent obstructive symptoms despite beta blockers and disopyramide was trialed on mavacamten. Although she had improvement in obstructive symptoms, mavacamten was stopped due to reduction in left ventricular ejection fraction even on the lowest dose. Instead, alcohol septal ablation was pursued. This case highlights key considerations surrounding septal reduction therapy in the era of mavacamten.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
回到原点:间隔缩小治疗在马夫卡坦时代的作用
一名86岁的肥厚性心肌病女性患者,尽管使用-受体阻滞剂和双双酰胺,但仍有持续的阻塞性症状。尽管她的阻塞性症状有所改善,但即使在最低剂量下,由于左心室射血分数降低,马伐camten也停止了治疗。取而代之的是酒精室间隔消融术。本病例强调了在马夫卡坦时代围绕间隔缩小治疗的关键考虑。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Management of pseudoaneurysm following primary percutaneous coronary intervention Extrinsic compression of the left main coronary artery in a child: Is a drug-eluting stent the best solution? Footprint of EluNIR-PERL stent as visualized by optical coherence tomography: A case report The role of coronary computed tomography angiography in the interventions of calcified coronary lesions: A case series TAVR with double chimney stenting from the same coronary cusp in anomalous and high-risk anatomy
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1